L
58
3
LNC
50
2
ORLY
58
2
UA
33
-2
RF
50
2
WFC
71
13
CF
26
-10
PRGO
65
3
PEP
48
-2
TSCO
52
-3
TAP
40
-4
BAC
53
3
MOS
22
2
SYF
97
2
HCA
50
2
STT
45
-11
PSA
40
3
MSFT
62
4
AKAM
50
2
AMZN
66
2
L
58
3
LNC
50
2
ORLY
58
2
UA
33
-2
RF
50
2
WFC
71
13
CF
26
-10
PRGO
65
3
PEP
48
-2
TSCO
52
-3
TAP
40
-4
BAC
53
3
MOS
22
2
SYF
97
2
HCA
50
2
STT
45
-11
PSA
40
3
MSFT
62
4
AKAM
50
2
AMZN
66
2
Financhill
Back

NeuroBo Pharmaceuticals 10K Form

Sell
40

NRBO
NeuroBo Pharmaceuticals

Last Price:
4.00
Seasonality Move:
-6.61%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive NRBO News And Ratings

See the #1 stock for the next 7 days that we like better than NRBO

NRBO Financial Statistics

Sales & Book Value

Annual Sales: --
Cash Flow: $-3.4M
Price / Cash Flow: 0
Annual Sales: $3.40
Price / Book: 1.14

Profitability

EPS (TTM): -2.38000
Net Income (TTM): $-12.47M
Gross Margin: --
Return on Equity: 0%
Return on Assets: 0%

NeuroBo Pharmaceuticals Earnings Forecast

Key NeuroBo Pharmaceuticals Financial Ratios

  • The Interest Expense is 0.00% of Operating Income.
  • Per Share Earnings over the last 10 years have been positive in 5 years.

NeuroBo Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: NRBO
CUSIP: 64132R
Website: neurobopharma.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

NRBO Technical Analysis vs Fundamental Analysis

Sell
40
NeuroBo Pharmaceuticals (NRBO) is a Sell

Is NeuroBo Pharmaceuticals a Buy or a Sell?